#1981 ·
gentlemoose62 said:I'm really curious about what this experimental immunotherapy being done in Germany actually entails, and whether it can be applied to all types of cancer or if it's strictly for melanoma.
Thanks
I don't know the exact list of every cancer type currently being targeted in this experimental phase, but it certainly isn't limited to just melanoma. My impression is that they focus heavily on melanoma because those patients often find themselves with very few other options left on the table. Generally speaking, the process involves dendritic cell programming—which is essentially a way of training certain white blood cells. They start by drawing blood and isolating the leukocytes, then they take those cells into a lab and inject them with tumor proteins. You get the most impressive results when you use specific tumor material harvested from the patient themselves, though if that's not available—like in our situation here where everything was already removed during surgery—they end up using material from a donor instead. Once these "trained" dendritic cells are injected back into the body, they pass along critical information to the cells responsible for hunting down tumors, effectively activating the immune system to go out and do its job. It feels simple, natural, and much less aggressive than traditional methods. Based on some articles I've been reading, there's an expectation that they will refine this method over the next couple of years until it becomes a standard protocol for treating various malignant diseases.